S. Ramaswamy, S. Boust, P. Sattar, S. Bhatia, F. Petty
{"title":"氯氮平与劳拉西泮合用的心源性猝死","authors":"S. Ramaswamy, S. Boust, P. Sattar, S. Bhatia, F. Petty","doi":"10.29046/jjp.019.1.005","DOIUrl":null,"url":null,"abstract":"OBJECTIVE: To report a case of sudden cardiac death in a patient taking a combination of clozapine and lorazepam. CASE SUMMARY: A 31-year-old white man with schizophrenia was found dead at his apartment. His medication regimen included clozapine 500 mg at bed time, lorazepam 0.5 mg three times daily and levothyroxine 75 mcg once a day. Autopsy studies revealed cardiac hypertrophy, pulmonary congestion and edema. DISCUSSION: Clozapine therapy may cause cardiomyopathy and reduction in heart rate variability (HRV) indices. Benzodiazepines can reduce vagal tone and increase sympathetic activity. This combination can have an enhanced potential for sudden cardiac death. CONCLUSIONS: Clozapineinduced cardiomyopathy and arrhythmias from clozapine and/or lorazepam use may have contributed to this man's death.","PeriodicalId":142486,"journal":{"name":"Jefferson Journal of Psychiatry","volume":"42 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sudden Cardiac Death with Clozapine and Lorazepam Combination\",\"authors\":\"S. Ramaswamy, S. Boust, P. Sattar, S. Bhatia, F. Petty\",\"doi\":\"10.29046/jjp.019.1.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"OBJECTIVE: To report a case of sudden cardiac death in a patient taking a combination of clozapine and lorazepam. CASE SUMMARY: A 31-year-old white man with schizophrenia was found dead at his apartment. His medication regimen included clozapine 500 mg at bed time, lorazepam 0.5 mg three times daily and levothyroxine 75 mcg once a day. Autopsy studies revealed cardiac hypertrophy, pulmonary congestion and edema. DISCUSSION: Clozapine therapy may cause cardiomyopathy and reduction in heart rate variability (HRV) indices. Benzodiazepines can reduce vagal tone and increase sympathetic activity. This combination can have an enhanced potential for sudden cardiac death. CONCLUSIONS: Clozapineinduced cardiomyopathy and arrhythmias from clozapine and/or lorazepam use may have contributed to this man's death.\",\"PeriodicalId\":142486,\"journal\":{\"name\":\"Jefferson Journal of Psychiatry\",\"volume\":\"42 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jefferson Journal of Psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29046/jjp.019.1.005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jefferson Journal of Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29046/jjp.019.1.005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Sudden Cardiac Death with Clozapine and Lorazepam Combination
OBJECTIVE: To report a case of sudden cardiac death in a patient taking a combination of clozapine and lorazepam. CASE SUMMARY: A 31-year-old white man with schizophrenia was found dead at his apartment. His medication regimen included clozapine 500 mg at bed time, lorazepam 0.5 mg three times daily and levothyroxine 75 mcg once a day. Autopsy studies revealed cardiac hypertrophy, pulmonary congestion and edema. DISCUSSION: Clozapine therapy may cause cardiomyopathy and reduction in heart rate variability (HRV) indices. Benzodiazepines can reduce vagal tone and increase sympathetic activity. This combination can have an enhanced potential for sudden cardiac death. CONCLUSIONS: Clozapineinduced cardiomyopathy and arrhythmias from clozapine and/or lorazepam use may have contributed to this man's death.